These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. Smit C; Wasmann RE; Goulooze SC; Wiezer MJ; van Dongen EPA; Mouton JW; Brüggemann RJM; Knibbe CAJ Br J Clin Pharmacol; 2020 Feb; 86(2):303-317. PubMed ID: 31661553 [TBL] [Abstract][Full Text] [Related]
4. Theophylline disposition in obesity. Gal P; Jusko WJ; Yurchak AM; Franklin BA Clin Pharmacol Ther; 1978 Apr; 23(4):438-44. PubMed ID: 630791 [TBL] [Abstract][Full Text] [Related]
5. Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin. Pai MP; Norenberg JP; Anderson T; Goade DW; Rodvold KA; Telepak RA; Mercier RC Antimicrob Agents Chemother; 2007 Aug; 51(8):2741-7. PubMed ID: 17548489 [TBL] [Abstract][Full Text] [Related]
6. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Bauer LA; Edwards WA; Dellinger EP; Simonowitz DA Eur J Clin Pharmacol; 1983; 24(5):643-7. PubMed ID: 6873144 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. van Kralingen S; Diepstraten J; Peeters MY; Deneer VH; van Ramshorst B; Wiezer RJ; van Dongen EP; Danhof M; Knibbe CA Clin Pharmacokinet; 2011 Nov; 50(11):739-50. PubMed ID: 21973271 [TBL] [Abstract][Full Text] [Related]
8. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673 [TBL] [Abstract][Full Text] [Related]
9. Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-551. PubMed ID: 28258392 [TBL] [Abstract][Full Text] [Related]
10. A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients. Smit C; Wasmann RE; Goulooze SC; Hazebroek EJ; Van Dongen EPA; Burgers DMT; Mouton JW; Brüggemann RJM; Knibbe CAJ Clin Pharmacokinet; 2019 Oct; 58(10):1333-1343. PubMed ID: 31016671 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects. Bunnell KL; Pai MP; Sikka M; Bleasdale SC; Wenzler E; Danziger LH; Rodvold KA Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311094 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of vancomycin in a morbidly obese patient. Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922 [TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Vance-Bryan K; Guay DR; Gilliland SS; Rodvold KA; Rotschafer JC Antimicrob Agents Chemother; 1993 Mar; 37(3):436-40. PubMed ID: 8460912 [TBL] [Abstract][Full Text] [Related]
15. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing. Kendrick JG; Carr RR; Ensom MH Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery. Xu B; Zhou D; Ren L; Shulman S; Zhang X; Xiong M J Anesth; 2017 Dec; 31(6):813-820. PubMed ID: 28828532 [TBL] [Abstract][Full Text] [Related]
18. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Healy DP; Polk RE; Garson ML; Rock DT; Comstock TJ Antimicrob Agents Chemother; 1987 Mar; 31(3):393-7. PubMed ID: 3579256 [TBL] [Abstract][Full Text] [Related]
19. Phenobarbital pharmacokinetics in obesity. A case report. Wilkes L; Danziger LH; Rodvold KA Clin Pharmacokinet; 1992 Jun; 22(6):481-4. PubMed ID: 1587059 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Rotschafer JC; Crossley K; Zaske DE; Mead K; Sawchuk RJ; Solem LD Antimicrob Agents Chemother; 1982 Sep; 22(3):391-4. PubMed ID: 7137982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]